The Paid up capital of the Company is less than Rs. 10/-(Ten) Crores and Net Worth of the Company is less than Rs. 25 /- (Twenty-Five)Crores as on 31.03.2025, so there is non-applicability of Reg 23(9) of SEBI (Listing Obligation and Disclosure Requirements) (Amendment) Regulation , 2018.
Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2025.
View original source (BSE India)Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Standalone Financial Result For The Period Ended On 30 September 2025
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025
- Rekvina Laboratories Ltd. Press Release Nov 05 2025
- Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November, 2025.
- Rekvina Laboratories Ltd. Press Release Oct 13 2025
Later from Rekvina Laboratories
- Closure of Trading Window
- Rekvina Laboratories Ltd. Press Release Dec 26 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Rekvina Laboratories Ltd. Press Release Jan 09 2026
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories